NCT06287606View on ClinicalTrials.gov

A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
Bowel Preparation
Interventions
DRUG

CTP0302-A

Subjects randomized into group CTP0302-A will take a bowel preparation from the evening until the following morning.

DRUG

CTP0302-B

Subjects randomized into group CTP0302-B will take a bowel preparation on the Colonoscopy day

DRUG

Conventional OST

Subjects randomized into group Conventional OST will take a bowel preparation from the evening until the following morning.

Trial Locations (1)

Unknown

Taejoon Pharmaceutical Co., Ltd., Seoul

All Listed Sponsors
lead

Taejoon Pharmaceutical Co., Ltd.

INDUSTRY

NCT06287606 - A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy | Biotech Hunter | Biotech Hunter